Clinical Trials Logo

Filter by:
NCT ID: NCT05494099 Recruiting - Clinical trials for Maxillary Sinus Disease

Extended Endoscopic Approaches to Non-malignant Maxillary Sinus Lesions Comparative

Start date: September 2022
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to compare the outcomes of endoscopic middle meatus mega-antrostomy, endoscopic pre-lacrimal recess approach and endoscopic modified medial maxillectomy regarding: 1.Assessment of the accessibility of each approach to visualize and reach the different walls and recesses of the maxillary sinus. 2. Any intraoperative or postoperative complications. 3. Any post-operative recurrence or residue detected by endoscopic examination. 4. Symptomatic relief by pre- and post-operative Sino-Nasal Outcome Test 22, Arabic translation and validation (SNOT-22) which is a reliable and valid outcome measure for CRS patients.

NCT ID: NCT05493527 Recruiting - Clinical trials for Respiratory Tract Diseases

Noninvasive High Frequency Oscillatory Ventilation as a Post-extubation Respiratory Support in Neonates

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

A randomized controlled trial comparing Noninvasive high frequency oscillatory ventilation (NHFOV) and Noninvasive positive pressure ventilation (NIPPV) as post-extubation respiratory support in preterm neonates with respiratory distress syndrome(RDS)

NCT ID: NCT05493228 Recruiting - Anesthesia Clinical Trials

Dexmedetomidine Infusion on Intraoperative Propofol,Fentanyl Requirements in Spine Surgery for Pediatric Cancer Patients

Start date: May 17, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to investigate whether the effect of a low-dose dexmedetomidine infusion will decrease propofol consumption or not through a double blinded randomized controlled trial done in children cancer hospital 57357.

NCT ID: NCT05493085 Recruiting - Clinical trials for Post Operative Pain, Acute

Quadratus Lumborum vs Caudal Epidural Block for Perioperative Analgesia in Pediatric Patients for Upper Abdominal Surgeries

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

Compare between the analgesic effect of the Ultrasound-guided quadratus lumborum block and single Caudal epidural injection in pediatric patients undergoing surgeries with supraumbilical incisions.

NCT ID: NCT05490082 Recruiting - Voiding Disorders Clinical Trials

Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation

Start date: March 1, 2022
Phase: Phase 3
Study type: Interventional

A randomized controlled study to compare the efficacy of mirabegron, solifenacin and propevirine for treatment of Lower urinary tract symptoms during intravesical BCG installation

NCT ID: NCT05488587 Recruiting - Clinical trials for Hepatocellular Carcinoma

Serum Levels of Some Trace Elements in Hepatocellular Carcinoma Patients

Start date: August 2022
Phase:
Study type: Observational

Hepatocellular carcinoma (HCC) is the sixth most frequent malignancy worldwide, with an estimated 906,000 new cases and 830,000 deaths in 2020. It is also the third leading cause for cancer deaths, with 15% 5-year survival rate . Diagnosis of HCC in cirrhotic patients is mainly based on non-invasive imaging techniques. Multiphasic computed tomography (CT) and dynamic contrast-enhanced magnetic resonance imaging (MRI) are the most sensitive imaging techniques for diagnosis of HCC. While the most common serologic marker for early screening of HCC is alpha-fetoprotein (AFP) . Liver is the main site of trace elements metabolism, and their levels are affected by different causes of liver disease .

NCT ID: NCT05487742 Recruiting - Clinical trials for Dexmedetomidine Neuroprotective Effect in Traumatic Brain Injury

Neuroprotective Effect of Dexomitomidine

Start date: June 4, 2022
Phase: Phase 1
Study type: Interventional

patient wih mild to moderate traumatic brain injury in ICU will be randomisly distributed into two groups Group I (control group): Patients of this group receive placebo infusion for 72 hours. Group II (DEX group): Patients of this group receive 0.5 ug/kg/hr dexmedetomidine continuous infusion for 72 hour Patient demographics, including age, sex, weight, primary diagnosis, Acute Physiology and Chronic Health Evaluation (APACHE) II score and postresuscitation Glasgow Coma Scale (GCS) score will be collected. CBF will be measured at pre-sedation and after cessation of sedation (dexmedetomidine administration). The CMRe and CMRe/CBF will also be calculated. Measurements of blood gas analysis and haemodynamic parameters [systolic blood pressure (SBP), diastolic blood pressure (DBP), MAP and heart rate (HR)] will be collected at pre-sedation and after cessation of sedation (dexmedetomidine administration).

NCT ID: NCT05486819 Recruiting - Clinical trials for Pain on Propofol Injection (POPI)

Lignocaine Versus Sodium Bicarbonate on Reducing Pain During Propofol Injection

Start date: August 1, 2022
Phase: Early Phase 1
Study type: Interventional

To compare the effect of adding lignocaine and sodium bicarbonate to propofol in reducing pain on propofol injection (POPI).

NCT ID: NCT05486429 Recruiting - Clinical trials for Non-Alcoholic Fatty Liver Disease

Evaluation of Lipid Profile in Different Grades of Non-alcoholic Fatty Liver Disease Diagnosed by Ultrasound

Start date: July 20, 2022
Phase:
Study type: Observational

Liver cells play a major role in the regulation of lipid metabolism. They are the principal location for lipoprotein and cholesterol synthesis. In healthy individuals an equilibrium is preserved between utilization, biosynthesis and transfer of lipid fractions. Many diseases that affect the parenchyma of liver can lead to changes in the structure of lipoprotein and transport through blood. Non - alcoholic fatty liver disease (NAFLD) is an abnormal accumulation of fat in the liver in the absence of secondary causes of fatty liver, such as significant alcohol use, viral hepatitis or medications that induce fatty liver. NAFLD is the most common liver disorder worldwide and is present in approximately 25%of the world's population [3]. People with NAFLD often have no symptoms and NAFLD is often only detectable during routine blood tests or unrelated abdominal imaging or liver biopsy [4].in some cases NAFLD can cause symptoms such as fatigue, malaise and dull right upper quadrant abdominal discomfort. Non - alcoholic steatohepatitis can severely impair liver functions leading to cirrhosis, liver failure and hepatocellular carcinoma. Grading of NAFLD on ultrasound: when the echogenicity is only marginally increases, it is grade 1, when the echogenic liver obscures the echogenic walls of portal vein branches, it is grade 2, and when the echogenic liver obscures the diaphragmatic outlines, it is grade 3 fatty infiltrations.

NCT ID: NCT05485558 Recruiting - Clinical trials for Drug Resistant Epilepsy

the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy

Start date: September 15, 2022
Phase: Phase 2
Study type: Interventional

This study aims at investigating the possible efficacy and safety of N-acetyl cysteine as adjuvant therapy in the treatment of drug-resistant epilepsy